InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by agnes lemarchand, Ancienne administratrice indépendante de bioMérieux. Officer active across 1 companies, notably BIOMERIEUX. In total, 5 reports have been logged. Total volume traded: €180k. The latest transaction was disclosed on 8 November 2022 — Acquisition. Regulator: AMF. All data is accessible without signup.
Declarations5 total
€60,2731,424 shares@ €42.32650.096% mcap100.0% of flow
ActionEuronext Paris
2022DD871705·
Ideal exit: 5 Aug 2023 (T+270)
€35,365343 shares@ €103.10460.0003% mcap45.1% of flow
ActionEuronext Paris
2021DD732416·
Ideal exit: 4 Sept 2022 (T+270)
€29,772230 shares@ €129.4450.0002% mcap38.0% of flow
ActionEuronext Paris
2021DD732415·
€13,308113 shares@ €117.770.0001% mcap17.0% of flow
ActionEuronext Paris
2021DD732413·
€41,028338 shares@ €121.38390.0003% mcap100.0% of flow
ActionEuronext Paris
2021DD732411·
Ideal exit: 5 Sept 2021 (T+270)
5 of 5 declarations
About agnes lemarchand
Agnès Lemarchand is a French business leader known for a career built in industry and in the governance of major listed companies, most notably bioMérieux, where she served as an independent board member from 2014 to 2024. She holds degrees from the École Nationale Supérieure de Chimie de Paris (ENSCP), the Massachusetts Institute of Technology (MIT), and an MBA from INSEAD. Her background combines technical training, international exposure, and operational leadership. She began her career within the Rhône-Poulenc group, where she held various industrial responsibilities from 1980 to 1985. In 1986, she was appointed Chief Executive Officer of Industrie Biologique Française (IBF). The following year, she founded IBF Biotechnics in the United States, a subsidiary created in the context of cooperation between Rhône-Poulenc and Institut Mérieux, and she became its Chairman and Chief Executive Officer. This early phase established her reputation as an executive capable of building and leading cross-border industrial operations. She later joined Ciments Français, where she served as Chief Executive Officer of Prodical from 1991 to 1996. She then moved into the building materials sector at Lafarge, where she led the group’s lime business as Chairman and Chief Executive Officer. In 2005, she took over Lafarge UK’s lime business together with key employees and founded Steetley Dolomite Ltd in the United Kingdom, where she served as Chairman. This part of her career highlights expertise in industrial restructuring, operational management, and entrepreneurial carve-outs. Alongside executive roles, Lemarchand held several board positions in prominent listed and industrial companies, including Saint-Gobain, CGG, Solvay, and bioMérieux. At bioMérieux, she served on the Audit Committee and the Strategy Committee, contributing to oversight, strategic review, and governance disciplines. Her profile is that of an experienced industrial executive and board member with strong credentials in corporate governance, international development, and strategic transformation.
